What amount sold does American Renal Associates Holdings, Inc. report in Form D filings?

The latest linked filings report $17.4M sold across 4 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was American Renal Associates Holdings, Inc.'s most recent SEC filing?

American Renal Associates Holdings, Inc.'s most recent Form D filing was on 2015-05-04.

How many investors does American Renal Associates Holdings, Inc. have?

The most recent Form D filing lists 3 investor(s).

What type of securities does American Renal Associates Holdings, Inc. offer?

American Renal Associates Holdings, Inc.'s SEC Form D filings indicate equity offerings.

American Renal Associates Holdings, Inc.

CIK: 0001498068·Other Health Care·BEVERLY, MA·Corporation·Founded 2010

Reported Sold

$17,413,729

Total Filings

Identified Offerings

Last Filed

May 4, 2015

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

May 4, 2015Form D — New notice

Reported sold: $155,838 · Target: Indefinite

Rule 506(b)·3 investors

Jun 13, 2014Form D — New notice

Reported sold: $5,000,000 · Target: $5,000,000

Rule 506(b)·151 investors

Jan 14, 2013Form D/A — Amendment

Reported sold: $9,422,891 · Target: $9,422,891

Rule 506·136 investors

Changed: Reported amount sold, Offering target, Reported investors

Jun 27, 2012Form D/A — Amendment

Reported sold: $4,777,703 · Target: $4,777,703

Rule 506·107 investors

Changed: Reported amount sold, Offering target, Reported investors

Nov 23, 2011Form D/A — Amendment

Reported sold: $4,331,349 · Target: $4,331,349

Rule 506·91 investors

Changed: Reported amount sold, Offering target, Reported investors

Nov 4, 2011Form D — New notice

Reported sold: $682,516 · Target: Indefinite

Rule 506·13 investors

Aug 18, 2010Form D — New notice

Reported sold: $2,835,000 · Target: $2,835,000

Rule 506·62 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

43%

Latest reported sold across 4 identified offerings

$17,413,729

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Joseph A. Carlucci

Related Person

Appears on 5 filings

Michael R. Costa

Related Person

Appears on 5 filings

Steven M. Silver

Related Person

Appears on 5 filings

Jared S. Hendricks

Related Person

Appears on 5 filings

Jon Wilcox

Related Person

Appears on 4 filings

Michael E. Boxer

Related Person

Appears on 4 filings

Thomas W. Erickson

Related Person

Appears on 4 filings

Syed T. Kamal

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
May 4, 2015	New	Indefinite	$155,838	3
Jun 13, 2014	New	$5,000,000	$5,000,000	151
Jan 14, 2013	Amendment	$9,422,891	$9,422,891	136
Jun 27, 2012	Amendment	$4,777,703	$4,777,703	107
Nov 23, 2011	Amendment	$4,331,349	$4,331,349	91
Nov 4, 2011	New	Indefinite	$682,516	13
Aug 18, 2010	New	$2,835,000	$2,835,000	62

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

XRHealth, Inc.

Other Health Care

Offering target: $3,877,693

Filed Oct 23, 2026